Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Named Patient Program (NPP), a compassionate use program of ABO 101

Next Previous
X
Search
Trial Profile

A Named Patient Program (NPP), a compassionate use program of ABO 101

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 04 Aug 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ABO-101 (Primary)
  • Indications Mucopolysaccharidosis III
  • Focus Expanded access; Therapeutic Use
  • Sponsors Abeona therapeutics

    • Most Recent Events

    • 04 Aug 2021 New trial record
    • 28 Jul 2021 According to an Abeona therapeutics media release, to date, three patients have been treated and a fourth patient will be treated with the higher dose through this program. The company intends to pool data from the all patients from "Transpher B" study and this "Named Patient Program " to assess therapeutic effect.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top